Insiders · ANTX

Eric Easom

Chief Executive Officer, Director at AN2 Therapeutics, Inc. (ANTX)

Eric Easom has filed 19 insider reports with the SEC since April 2022, as chief Executive Officer and director at AN2 Therapeutics, Inc. (ANTX). Eric Easom made no open-market purchases or sales in the last 12 months. The latest filing, on March 23, 2026, reports grant or award and sale back to the company at AN2 Therapeutics, Inc. (ANTX).

Filings
19
Companies
1
Bought on market
$114K
Sold on market
$1.55M

Companies where Eric Easom is an insider

CompanyRoleShares heldBoughtSoldAvg buyPrice nowLast filing
AN2 Therapeutics, Inc. logo
ANTX
AN2 Therapeutics, Inc.
Chief Executive Officer, Director368,630$114K$1.55M$1.63$4.95+204%Mar 23, 2026

Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record. Price now: the latest daily close, against the average buy price.

Every filing

Compare Eric Easom with

Other insiders at the same companies

Questions about Eric Easom

What is Eric Easom's role at AN2 Therapeutics, Inc.?
Eric Easom reports to the SEC as chief Executive Officer and director at AN2 Therapeutics, Inc. (ANTX), according to the latest filing on March 23, 2026.
How many shares does Eric Easom own?
After the latest filing that states it, Eric Easom directly owned 368,630 shares of AN2 Therapeutics, Inc. (ANTX). Shares held through trusts, funds or family members are reported separately and are not counted here.
Has Eric Easom bought or sold stock recently?
The most recent open-market purchase was on June 2, 2025: bought 10,000 shares of AN2 Therapeutics, Inc. (ANTX) for $10.7K at an average of $1.07. The most recent open-market sale was on January 2, 2024: sold 2,777 shares of AN2 Therapeutics, Inc. (ANTX) for $55.8K at an average of $20.09.
How do I get alerts when Eric Easom files?
Follow Eric Easom on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.

From SEC Forms 3, 4, 5 and 144 filed by Eric Easom (SEC CIK 0001914503). Totals count each trade once, skipping amendments whose original is on file, from Apr 1, 2022 on. View on SEC EDGAR